Clinical Trials Logo

Thyroid clinical trials

View clinical trials related to Thyroid.

Filter by:

NCT ID: NCT04860622 Completed - Pregnancy Related Clinical Trials

Normal Range of TSH and FT4 in Pregnancy

NRTSHTURKEY
Start date: April 1, 2021
Phase:
Study type: Observational [Patient Registry]

Physiological changes necessitate the use of pregnancy-specific reference ranges for thyrotrophin (TSH) and free T4 (FT4) to diagnose thyroid dysfunction during pregnancy. Although many centers use fixed upper limits for TSH of 2.5 or 3.0 mU/L, this may lead to overdiagnosis or even overtreatment. The new guidelines of the American Thyroid Association have considerably changed recommendations regarding thyroid function reference ranges in pregnancy accordingly. Any hospital or physician that is still using the 2.5 or 3.0 mU/l cut-off for TSH during pregnancy should evaluate their own lab-specific cut-offs. The investigator's objective is to establish a rational reference range of serum TSH for the diagnosis of subclinical hypothyroidism in the first, second, and third trimester of pregnant women in the Sancaktepe region in Turkey.

NCT ID: NCT04845867 Not yet recruiting - Thyroid Clinical Trials

Thyroid HEmorrhage DetectOr Study

HEDOS
Start date: July 1, 2021
Phase:
Study type: Observational [Patient Registry]

After thyroid surgery, 0.6 to 4% of patients develop postoperative bleeding. 90% of this postoperative bleeding occurs within the first 48 hours. Most of the time, the complications are rapidly progressing and require immediate attention. Up to 0.6% of patients with postoperative bleeding die. In a clinical study with postoperative pressure measurements it could be shown that postoperative bleeding without interruption leads to a continuous increase in pressure in the neck, as is observed when coughing and pressing. Systematic invasive pressure measurement in the thyroid compartment after surgery might detect a continuous increase in pressure which is often caused by a growing haematoma, indicating serious post-surgery bleeding at a much earlier time compared to state of the art diagnostic workflow. n routine clinical care, detection of serious haemorrhage depends on the patients alerting symptoms even if post-operative intermittent monitoring of vital parameters and wound conditions is performed according to current medical guidelines [18] and local instructions. Device-based, continuous haemorrhage detection within 36 to 48 hours after surgery would allow to objectively measure an increase in cervical pressure before symptoms occur, i.e. early detection of risk leading to timely therapeutic actions. Thus, the risk of serious complications like hypoxic brain damage and death caused by post-operative haemorrhage is minimized. In addition, the intervention team would be able to fine-tune necessary actions during the rescue procedure based on objective pressure values, e.g. the decision to open cutaneous sutures immediately or later in the operation theatre, and therefore reduce additional perioperative morbidity and increase patients' safety.

NCT ID: NCT04830293 Completed - Thyroid Clinical Trials

Effect of Head Position During Thyroidectomy on Postoperative Cognitive Functions

Start date: March 1, 2019
Phase:
Study type: Observational [Patient Registry]

The aim of our study is to observe the effect of head-neck position of patients scheduled for thyroidectomy, on carotid artery blood flow, regional cerebral oxygen saturation measured using near-infrared spectroscopy technology, and postoperative cognitive dysfunction.

NCT ID: NCT04763122 Completed - Cancer Clinical Trials

Thyroid Cancer in United Arab Emirates

Start date: September 2008
Phase:
Study type: Observational

The main objective of the study is to assess the trend of clinicopathological features and treatment modalities in patients with thyroid cancer in the largest oncology center in the United Arab Emirates (UAE).

NCT ID: NCT04684953 Not yet recruiting - Thyroid Clinical Trials

Thyroid Autotransplantation in Quadriceps Femoris Muscle

Start date: January 2022
Phase: N/A
Study type: Interventional

providing an almost natural ectopic thyroid in patients undergoing total thyroidectomy, remains a challenging subject that can benefits patients with a non-pharmacological substitute for their normal gland. this study seeks to prove that thyroid autotransplantation is possible and reliable.

NCT ID: NCT04647006 Completed - Surgery Clinical Trials

Comparison of TOETVA and Conventional Thyroidectomy

TOETVA
Start date: September 23, 2019
Phase: N/A
Study type: Interventional

Introduction-Objective: The application of transoral endoscopic thyroidectomy vestibular approach (TOETVA) is gradually increasing recently. However, it is not clear whether TOETVA is a true minimally invasive thyroidectomy compared to open conventional thyroidectomy. In this study, we aimed to evaluate the TOETVA and open conventional thyroidectomy techniques in terms of postoperative inflammatory response, pain and patient satisfaction. Material and Method: In this prospective study, 40 female patients between the ages of 18-65 were divided into 2 groups of 20 patients: TOETVA: 20 patients, open thyroidectomy: 20 patients. Operation time, inflammatory response with IL-6, white blood cell (WBC) and C-reactive protein (CRP), postoperative pain, postoperative complications and patient satisfaction were evaluated in both groups.

NCT ID: NCT04623801 Recruiting - Thyroid Cancer Clinical Trials

Laser Ablation of Papillary Thyroid Microcarcinoma

Start date: October 19, 2020
Phase: Phase 2
Study type: Interventional

The purpose of this study is to explore whether percutaneous laser ablation (PLA) is a safe and effective alternative to removing papillary thyroid microcarcinoma (PTMC) with surgery.

NCT ID: NCT04615988 Recruiting - Cancer Clinical Trials

Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors

Start date: June 9, 2021
Phase:
Study type: Observational

The purpose of this research study is to see if the amount of vitamin D in ones blood makes it more or less likely to develop thyroid gland toxicity when being treated with immunotherapy that blocks the activity of proteins called programed death-1(PD-1) or programmed death ligand-1 (PD-L1). Immunotherapy is treatment that makes changes to the immune system to try to fight cancer. Immunotherapy treatments that block the activity of important parts of the immune system called PD-1 and PD-L1 are used to standardly treat many different types of cancer and can cause thyroid toxicity in certain people. In this study the treatment for your cancer is not research treatment but standard of care determined by your oncologist. Blood will be drawn before starting treatment to determine the amount of Vitamin D and also to assess thyroid function. Also questionnaires will be completed before starting treatment and while on treatment to assess symptoms you are experiencing.

NCT ID: NCT04571736 Recruiting - Thyroid Clinical Trials

Pilot Study for Thyroid Surgery by Preoperative Video Support and Personalized and Secure Web Platform

AMEDOP
Start date: November 18, 2020
Phase: N/A
Study type: Interventional

The medical information delivered to the patient before any surgery constitutes an essential and compulsory step during the initial management of the operated patient. There are different reasons for the quantity and quality of medical information retained by the patient. An internet platform with personalized and secure access has been developed. This platform contains, among other things, an explanatory video of thyroid surgery and allows the patient to have access to information on surgical management at any time. The investigators believe that unlimited access for the duration of the study to this platform could reduce the preoperative anxiety level of patients.

NCT ID: NCT04388956 Recruiting - Diagnoses Disease Clinical Trials

Thyroid Disease Diagnosis by Mutiple Ultrasonic Factors.

Start date: July 2008
Phase:
Study type: Observational [Patient Registry]

In the outpatient clinic based population setting, the investigators want to reappraise the accuracy of the new model of multi-factorial ultrasound diagnosis with the conventional fine-needle aspiration cytology.